Assyro AI

Orange Book product · Generic (ANDA)

DICLOFENAC POTASSIUM

DICLOFENAC POTASSIUM

Generic (ANDA)ANDA 218011TE ABRX TARO
View DICLOFENAC POTASSIUM familyOpen on FDA Orange Book

At a glance

Jun 14, 2024

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 14, 2024

    2 yr 1 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

DICLOFENAC POTASSIUM

Strength

50MG

Dosage form

FOR SOLUTION

Route

ORAL

TE code

AB

Application

ANDA 218011

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of DICLOFENAC POTASSIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo